1. Home
  2. EBS vs BWMX Comparison

EBS vs BWMX Comparison

Compare EBS & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • BWMX
  • Stock Information
  • Founded
  • EBS 1998
  • BWMX 1995
  • Country
  • EBS United States
  • BWMX Mexico
  • Employees
  • EBS N/A
  • BWMX N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • BWMX Catalog/Specialty Distribution
  • Sector
  • EBS Health Care
  • BWMX Consumer Discretionary
  • Exchange
  • EBS Nasdaq
  • BWMX Nasdaq
  • Market Cap
  • EBS 529.9M
  • BWMX 495.6M
  • IPO Year
  • EBS 2006
  • BWMX N/A
  • Fundamental
  • Price
  • EBS $10.93
  • BWMX $14.38
  • Analyst Decision
  • EBS Strong Buy
  • BWMX Strong Buy
  • Analyst Count
  • EBS 1
  • BWMX 2
  • Target Price
  • EBS $15.00
  • BWMX $22.50
  • AVG Volume (30 Days)
  • EBS 1.5M
  • BWMX 35.3K
  • Earning Date
  • EBS 10-29-2025
  • BWMX 10-23-2025
  • Dividend Yield
  • EBS N/A
  • BWMX 10.09%
  • EPS Growth
  • EBS N/A
  • BWMX 15.49
  • EPS
  • EBS 1.35
  • BWMX 1.49
  • Revenue
  • EBS $788,900,000.00
  • BWMX $775,128,445.00
  • Revenue This Year
  • EBS N/A
  • BWMX $3.50
  • Revenue Next Year
  • EBS $15.42
  • BWMX $5.30
  • P/E Ratio
  • EBS $8.11
  • BWMX $9.60
  • Revenue Growth
  • EBS N/A
  • BWMX 3.60
  • 52 Week Low
  • EBS $4.02
  • BWMX $7.00
  • 52 Week High
  • EBS $13.41
  • BWMX $15.00
  • Technical
  • Relative Strength Index (RSI)
  • EBS 57.23
  • BWMX 58.63
  • Support Level
  • EBS $9.02
  • BWMX $13.41
  • Resistance Level
  • EBS $10.29
  • BWMX $14.65
  • Average True Range (ATR)
  • EBS 0.58
  • BWMX 0.50
  • MACD
  • EBS -0.03
  • BWMX -0.03
  • Stochastic Oscillator
  • EBS 93.69
  • BWMX 74.42

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About BWMX Betterware de Mexico S.A.P.I. de C.V.

Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.

Share on Social Networks: